|
|
 |
|
Total Number of Holdings (excluding cash): 50
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$81,404.92 |
2.82% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$77,602.14 |
2.69% |
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$74,566.47 |
2.58% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$74,352.69 |
2.57% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$73,893.40 |
2.56% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$71,686.62 |
2.48% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$71,569.77 |
2.48% |
| Waters Corporation |
WAT |
941848103 |
184 |
$70,363.44 |
2.44% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$67,533.76 |
2.34% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$66,756.18 |
2.31% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$65,425.62 |
2.27% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$65,278.32 |
2.26% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$65,317.68 |
2.26% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$64,912.08 |
2.25% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$63,451.74 |
2.20% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$63,495.67 |
2.20% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$63,167.04 |
2.19% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$62,878.85 |
2.18% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$60,403.10 |
2.09% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$59,980.84 |
2.08% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$59,934.15 |
2.08% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$59,675.00 |
2.07% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$59,241.00 |
2.05% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$58,769.60 |
2.03% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$58,434.54 |
2.02% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$58,150.44 |
2.01% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$57,201.60 |
1.98% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$56,586.20 |
1.96% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$56,748.45 |
1.96% |
| Steris Plc |
STE |
G8473T100 |
265 |
$55,819.60 |
1.93% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$55,438.76 |
1.92% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$55,500.78 |
1.92% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$55,173.83 |
1.91% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$54,292.66 |
1.88% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$53,160.97 |
1.84% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$52,374.48 |
1.81% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$51,626.17 |
1.79% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$50,718.60 |
1.76% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$50,025.93 |
1.73% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$50,109.86 |
1.73% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$49,507.62 |
1.71% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$49,173.84 |
1.70% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$47,514.00 |
1.65% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$43,868.88 |
1.52% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$44,030.85 |
1.52% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$43,785.30 |
1.52% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$43,162.60 |
1.49% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$41,618.90 |
1.44% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$37,756.56 |
1.31% |
| US Dollar |
$USD |
|
14,881 |
$14,880.63 |
0.52% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|